EPCAM and colorectal carcinoma: EpCAM is also among the first markers to effectively identify CSCs in PDAC (Ishiwata et al., 2018), CRC (Dalerba et al., 2007) and GC (Dai et al., 2017), making it a promising candidate for the identification of CSCs in GI cancers.